Patent details
EP1613328 Title: USE OF CARBAMAZEPINE DERIVATIVES FOR THE TREATMENT OF AGITATION IN DEMENTIA PATIENTS
Basic Information
- Publication number:
- EP1613328
- PCT Application Number:
- PCT/EP/2004/003418
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP047245998
- PCT Publication Number:
- WO/2004/087166
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USE OF CARBAMAZEPINE DERIVATIVES FOR THE TREATMENT OF AGITATION IN DEMENTIA PATIENTS
- French Title of Invention:
- UTILISATION DE DERIVES DE CARBAMAZEPINE DANS LE TRAITEMENT DE L'AGITATION CHEZ DES PATIENTS ATTEINTS DE DEMENCE
- German Title of Invention:
- VERWENDUNG VON CARBAMAZEPINDERIVATEN ZUR BEHANDLUNG VON AGITATIO IN DEMENSPATIENTEN
- SPC Number:
Dates
- Filing date:
- 31/03/2004
- Grant date:
- 18/03/2009
- EP Publication Date:
- 18/03/2009
- PCT Publication Date:
- 14/10/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 11/01/2006
- EP B1 Publication Date:
- 18/03/2009
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 31/03/2009
- Expiration date:
- 31/03/2024
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/03/2009
- Name:
- NOVARTIS AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- MARTENYI Ferenc
- Address:
- Hungary (HU)
2
- Name:
- SHUA-HAIM Joshua
- Address:
- United States (US)
Priority
- Priority Number:
- 459338 P
- Priority Date:
- 01/04/2003
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/55;
| Filing date | Document type | Number of pages |
|---|